In the tumor microenvironment, administration of PD‐L1 nb plasmids reduced PD‐1 expression on CD8+ T cells and mitigated T cell exhaustion, while co‐administration with GM‐CSF‐peptides significantly increased memory CD8+ T cells and activated CD8+ T cells (CD8+CD69+). Here, CD69 is linked to neoplasm.